The list below is a sampling of the open BMT clinical trials for AML at University of Minnesota Medical Center. Click on the highlighted links
below for a printable pdf summary of selected studies.  We will be adding new summaries in the future, so please be sure to visit us again. For information on additional trials, please call 612-273-2800.

Newly Diagnosed

ECOG: Auto Tranplantation for AML (MT 2007-02)

CR1 (including High Risk)

Allo Transplant for Heme Malignancy (MT 2001-02)

Reduced Intensity Allo Bone Marrow Transplant (MT 2001-10)

Myeloablative UCB Transplant for Heme Malignancy (MT 2005-10)

Reduced Intensity UCB Transplant (MT 2005-02)

CTN: Reduced Intensity Transplant for AML in Older Patients (MT 2006-23)

Reduced Intensity Haplo Transplant with NK for Myeloid Malignancies (MT 2003-23)

Auto Transplant for AML (MT 2006-13)

Expanded Human Myeloid Progenitor Cells post Allo UCB for Heme Malignancy (MT 2008-38)

ECOG: Auto Transplantation for Heme Malignancy (MT 2000-23)

UCB Tregs after Reduced Intensity Transplant (MT 2006-18)

CTN: Siro/Tac vs. Mtx/Tac for GVHD Prophylaxis (MT 2006-18)

Reduced Intensity Haploidentical Transplant Supplemented with Donor Natural Killer Cells (MT 2003-23)

CR2 or later

Allo Transplant for Heme Malignancy (MT 2001-02)

Reduced Intensity Allo Bone Marrow Transplant (MT 2001-10)

Myeloablative UCB Transplant for Heme Malignancy (MT 2005-10)

Reduced Intensity UCB Transplant (MT 2005-02)

CTN: Reduced Intensity Transplant for AML in Older Patients (MT 2006-23)

Reduced Intensity Haplo Transplant for NK for Myeloid Malignancies (MT 2003-23)

Auto Transplant for AML (MT 2006-13)

Expanded Human Myeloid Progenitor Cells post Allo UCB for Heme Malignancy (MT 2008-38)

ECOG: Auto Transplantation for Heme Malignancy (MT 2000-12)

Treg in Sibling Allo Transplant (Mt 2006-01)

UCB Tregs after Reduced Intensity Transplant (MT 2006-01)

CTN: Siro/Tac vs. MtxTac fpr GVHD Prophylaxis (MT 2006-18)

Reduced Intensity UCB Transplant with C3a Priming (MT 2008-15)

Advanced/Relapsed AML

Allo Transplant for Heme Malignancy (MT 2001-02)

Reduced Intensity Allo Bone Marrow Tranplant (MT 2001-10)

Reduced Intensity Haplo Transplant with NK for Myeloid MalMalignancies (MT 2003-23)

Myeloablative UCB Transplant for Heme Malignancy (MT 2005-10)

Velcade + Vorinostat for MDS/AML (Mt 2008-08)

Reduced Intensity Haploidentical Transplant Supplemented with Donor Natural Killer Cells (MT 2003-23)

Myeloablative T-Cell Depleted UCB with IL-2 +NK for Refractory AML (MT 2008-36)

Ly573636-Sodium for Relapsed or Refractory Acute Myeloid Leukemia (MT 2008-08)

Haplo NK Cells for Refractory or Relapsed AML (MT 2010-02)